Results 131 to 140 of about 86,096 (311)

We did it! How to organise community-based prevention of drug misuse.

, 1997
This short document described an approach to community-based prevention of drug misuse, which used methodology based on the experience of projects in Belgium, Portugal, the United Kingdom and Ireland.
Murphy, Chris, Butler, Elaine, Wall, Kathryn, Roe, Bernie   +3 more
core  

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran, Véronique Moysan, Bruno Lescarret, Clément Mathieu, Antoine Pariente, Nicolas Rousselot   +5 more
wiley   +1 more source

Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study. [PDF]

BMC Public Health, 2023
Al Rawwad T, Tata V, Wanat MA, Campbell D, Thornton D.   +4 more
europepmc   +1 more source

Government strategy to prevent drug misuse.

, 1991
In May 1990 the Minister for Health reconstituted and strengthened the National Co-ordinating Committee on Drug Abuse, originally established in 1985. This document summarised the recommendations of this reconstituted committee, and the recommendations ...

core  

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari, Caroline S. Copeland, Georgia C. Richards   +2 more
wiley   +1 more source

Drug and alcohol misuse in first episode psychosis: An observational study

Neuropsychiatric Disease and Treatment, 2008
Kathleen Crebbin, Emma Mitford, Roger Paxton, Douglas TurkingtonPACE Project, St George’s Park, Morpeth, Northumberland, UKBackground: There have been very few observational studies of drug and alcohol misuse in first-episode psychosis in the ...
Kathleen Crebbin, Emma Mitford, Roger Paxton, Douglas Turkington   +3 more
doaj  

Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review. [PDF]

Brain Sci, 2022
Schifano N, Chiappini S, Mosca A, Miuli A, Santovito MC, Pettorruso M, Capogrosso P, Dehò F, Martinotti G, Schifano F.   +9 more
europepmc   +1 more source

Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues

British Journal of Clinical Pharmacology, EarlyView.
Background and Purpose Although opioids are central to end of life (EoL) care, tissue‐level opioid exposure remains poorly understood. The objective of this study was to characterize the relationship between prescription‐derived morphine equivalent daily dose (MEDD) and measured morphine concentrations across multiple organs.
Niamh Higgins, Alan Wells, Nimish Patel, Nicole Muttera, Mattia Trunfio, Alessandra Manca, Amedeo De Nicolò, Micol Ferrara, Stefano Bonora, Jessica Cusato, Alice Palermiti, Antonio D'Avolio, Marissa Borochoff, Patricia K. Riggs, Elizabeth Hastie, Rabia S. Atayee, Stephanie Solso, Cheryl Dullano, Vanessa Gomez‐Moreno, Tara Tenenbaum, Robert Deiss, Davey M. Smith, Antoine Chaillon, Sara Gianella   +23 more
wiley   +1 more source

Theory, Measurement, and Psychometric Properties of Risk and Protective Factors for Drug Misuse Among Adolescents Living on or near the Cherokee Nation Reservation. [PDF]

Advers Resil Sci, 2023
Livingston MD, Barry CM, Jagtiani A, Kominsky TK, Skinner JR, Livingston BJ, Harmon M, Ivanich EA, Cooper HLF, Wagenaar AC, Komro KA.   +10 more
europepmc   +1 more source

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source